Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use

Lem Taylor, Petey Mumford, Mike Roberts, Sara Hayward, Jacy Mullins, Stacie Urbina, Colin Wilborn, Lem Taylor, Petey Mumford, Mike Roberts, Sara Hayward, Jacy Mullins, Stacie Urbina, Colin Wilborn

Abstract

Background: Theacrine (1,3,7,9-tetramethyluric acid) is a purine alkaloid found in certain coffee (Coffea) species, fruits (Cupuacu [Theobroma grandiflorum]), and tea (Camellia assamica, var. kucha) that has anti-inflammatory, analgesic, and neuro-locomotor properties. Recent preliminary research has also reported increased feelings of energy, reduced fatigue, and strong effects on improving focus, concentration, and motivation to exercise. The purpose of this study was to examine the safety and non-habituating effects of TeaCrine®, a nature-identical, chemically equivalent bioactive version of theacrine.

Methods: Sixty healthy men (mean ± SD age, height, weight: 22.9 ± 4.7 years, 183.5 ± 9.2 cm, 86.5 ± 13.7 kg) and women (22.3 ± 4.5 years, 165.2 ± 12.3 cm, 69.0 ± 17.4 kg) were placed into one of three groups: placebo (PLA, n = 20), 200 mg TeaCrine® (LD, n = 19) or 300 mg Teacrine® (HD, n = 21) and ingested their respective supplement once daily for 8 weeks. Primary outcomes were fasting clinical safety markers (heart rate, blood pressure, lipid profiles, hematologic blood counts, biomarkers of liver/kidney/immune function) and energy, focus, concentration, anxiety, motivation to exercise, and POMS measured prior to daily dosing to ascertain potential tachyphylactic responses and habituation effects. Data were analyzed via two-way (group × time) ANOVAs and statistical significance was accepted at p < 0.05.

Results: All values for clinical safety markers fell within normal limits and no group × time interactions were noted. No evidence of habituation was noted as baseline values for energy, focus, concentration, anxiety, motivation to exercise, and POMS remained stable in all groups across the 8-week study protocol.

Conclusions: These findings support the clinical safety and non-habituating neuro-energetic effects of TeaCrine® supplementation over 8 weeks of daily use (up to 300 mg/day). Moreover, there was no evidence of a tachyphylactic response that is typical of neuroactive agents such as caffeine and other stimulants.

Keywords: Habituation; Safety; Theacrine.

Figures

Fig. 1
Fig. 1
Between-treatment effects on body composition variables are illustrated in graph (a) Body mass, (b) Body fat mass, (c) Dry lean mass, and (d) Body fat %. Abbreviations: PLA, Placebo; LD, Theacrine Low Dose; HD, Theacrine High Dose. There were no main effects of time, group*time interactions or group*time*gender interactions for select body composition variables

References

    1. Zheng XQ, Ye CX, Kato M, Crozier A, Ashihara H. Theacrine (1,3,7,9-tetramethyluric acid) synthesis in leaves of a Chinese tea, kucha (Camellia assamica var. kucha) Phytochemistry. 2002;60(2):129–34. doi: 10.1016/S0031-9422(02)00086-9.
    1. Habowski SM, Sandrock JE, Kedia AW, Ziegenfuss T. The effects of TeacrineTM, a nature-identical purine alkaloid, on subjective measures of cognitive function, psychometric and hemodynamic indices in healthy humans: a randomized, double-blinded crossover pilot trial. J Int Soc Sports Nutr. 2014;11(1):1–2. doi: 10.1186/1550-2783-11-1.
    1. Feduccia AA, Wang Y, Simms JA, Yi HY, Li R, Bjeldanes L, et al. Locomotor activation by theacrine, a purine alkaloid structurally similar to caffeine: involvement of adenosine and dopamine receptors. Pharmacol Biochem Behav. 2012;102(2):241–8. doi: 10.1016/j.pbb.2012.04.014.
    1. Wang Y, Yang X, Zheng X, Li J, Ye C, Song X. Theacrine, a purine alkaloid with anti-inflammatory and analgesic activities. Fitoterapia. 2010;81(6):627–31. doi: 10.1016/j.fitote.2010.03.008.
    1. Li SB, Li YF, Mao ZF, Hu HH, Ouyang SH, Wu YP, et al. Differing chemical compositions of three teas may explain their different effects on acute blood pressure in spontaneously hypertensive rats. J Sci Food Agric. 2015;95(6):1236–42. doi: 10.1002/jsfa.6811.
    1. Outlaw J, Wilborn C, Smith A, Urbina S, Hayward S, Foster C, et al. Effects of ingestion of a commercially available thermogenic dietary supplement on resting energy expenditure, mood state and cardiovascular measures. J Int Soc Sports Nutr. 2013;10(1):25. doi: 10.1186/1550-2783-10-25.
    1. Chen YM, Liu Y, Liu YH, Wang X, Guan K, Zhu HL. Higher serum concentrations of betaine rather than choline is associated with better profiles of DXA-derived body fat and fat distribution in Chinese adults. Int J Obes. 2015;39(3):465–71. doi: 10.1038/ijo.2014.158.
    1. Goldstein ER, Ziegenfuss T, Kalman D, Kreider R, Campbell B, Wilborn C, et al. International society of sports nutrition position stand: caffeine and performance. J Int Soc Sports Nutr. 2010;7(1):5. doi: 10.1186/1550-2783-7-5.
    1. Vogel RM, Joy JM, Falcone PH, Mosman MM, Kim MP, Moon JR. Consuming a multi-ingredient thermogenic supplement for 28 days is apparently safe in healthy adults. Food Nutr Res. 2015;59:27999. doi: 10.3402/fnr.v59.27999.
    1. Church DD, Hoffman JR, LaMonica MB, Riffe JJ, Hoffman MW, Baker KM, et al. The effect of an acute ingestion of Turkish coffee on reaction time and time trial performance. J Int Soc Sports Nutr. 2015;12:37. doi: 10.1186/s12970-015-0098-3.
    1. Lee KA, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res. 1991;36(3):291–8. doi: 10.1016/0165-1781(91)90027-M.
    1. Kruskall LJ, Campbell WW, Evans WJ. The Yale Physical Activity Survey for older adults: predictions in the energy expenditure due to physical activity. J Am Diet Assoc. 2004;104(8):1251–7. doi: 10.1016/j.jada.2004.05.207.
    1. Ziegenfuss TN, Habowski SM, Lemieux R, Sandrock JE, Kedia AW, Kerksick CM, et al. Effects of a dietary supplement on golf drive distance and functional indices of golf performance. J Int Soc Sports Nutr. 2015;12(1):4. doi: 10.1186/s12970-014-0065-4.
    1. Trevisanato SI, Kim YI. Tea and health. Nutr Rev. 2000;58(1):1–10. doi: 10.1111/j.1753-4887.2000.tb01818.x.
    1. Weisburger JH. Tea and health: a historical perspective. Cancer Lett. 1997;114(1-2):315–7. doi: 10.1016/S0304-3835(97)04691-0.
    1. Sarma DN, Barrett ML, Chavez ML, Gardiner P, Ko R, Mahady GB, et al. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf. 2008;31(6):469–84. doi: 10.2165/00002018-200831060-00003.
    1. Riksen NP, Rongen GA, Smits P. Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease. Pharmacol Ther. 2009;121(2):185–91. doi: 10.1016/j.pharmthera.2008.10.006.
    1. Xu JK, Kurihara H, Zhao L, Yao XS. Theacrine, a special purine alkaloid with sedative and hypnotic properties from Cammelia assamica var. kucha in mice. J Asian Nat Prod Res. 2007;9(6-8):665–72. doi: 10.1080/10286020601103155.
    1. Satoh S, Matsumura H, Hayaishi O. Involvement of adenosine A2A receptor in sleep promotion. Eur J Pharmacol. 1998;351(2):155–62. doi: 10.1016/S0014-2999(98)00302-1.
    1. Satoh S, Matsumura H, Koike N, Tokunaga Y, Maeda T, Hayaishi O. Region-dependent difference in the sleep-promoting potency of an adenosine A2A receptor agonist. Eur J Neurosci. 1999;11(5):1587–97. doi: 10.1046/j.1460-9568.1999.00569.x.
    1. Ali M. Pharmacognosy (pharmacognosy and phytochemistry) New Delhi: CBS Publishers & Distributors Pvt. Ltd; 2008.
    1. Ikeda I, Imasato Y, Sasaki E, Nakayama M, Nagao H, Takeo T, et al. Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim Biophys Acta. 1992;1127(2):141–6. doi: 10.1016/0005-2760(92)90269-2.
    1. Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, et al. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med. 2003;163(12):1448–53. doi: 10.1001/archinte.163.12.1448.
    1. Westerterp-Plantenga MS, Lejeune MP, Kovacs EM. Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res. 2005;13(7):1195–204. doi: 10.1038/oby.2005.142.
    1. Anaya AL, Cruz-Ortega R, Waller GR. Metabolism and ecology of purine alkaloids. Front Biosci. 2006;11:2354–70. doi: 10.2741/1975.
    1. Ashihara H, Sano H, Crozier A. Caffeine and related purine alkaloids: biosynthesis, catabolism, function and genetic engineering. Phytochemistry. 2008;69(4):841–56. doi: 10.1016/j.phytochem.2007.10.029.
    1. Kovacs EM, Lejeune MP, Nijs I, Westerterp-Plantenga MS. Effects of green tea on weight maintenance after body-weight loss. Br J Nutr. 2004;91(3):431–7. doi: 10.1079/BJN20041061.
    1. Hursel R, Viechtbauer W, Westerterp-Plantenga MS. The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int J Obes. 2009;33(9):956–61. doi: 10.1038/ijo.2009.135.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する